$16.28 +0.23 (%) Cempra Inc - NASDAQ

Jun. 28, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Cempra Prices ~4.166M Share Offering @$24.00/Share

    Benzinga | Jan. 7, 2016 | 04:14AM EST
  2. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 6, 2016 | 08:22AM EST
  3. 6 Stocks Moving In Tuesday's After-Hours Session

    Benzinga | Jan. 5, 2016 | 16:59PM EST
  4. 8 Stocks Moving In Monday's After-Hours Session

    Benzinga | Jan. 4, 2016 | 16:50PM EST
  5. Benzinga's Top Initiations

    Benzinga | Dec. 11, 2015 | 09:58AM EST
  6. Benzinga's Top Upgrades

    Benzinga | Nov. 16, 2015 | 08:54AM EST
  7. Cempra Rallies Over $4 Off Friday's Low ($15.43)

    Benzinga | Oct. 27, 2015 | 11:09AM EST
  8. Morning Market Losers

    Benzinga | Oct. 19, 2015 | 09:50AM EST
  9. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 19, 2015 | 08:24AM EST
  10. Mid-Afternoon Market Update: Crude Oil Rises 2%; Zafgen Shares Dip On Beloranib Partial Clinical Hold

    Benzinga | Oct. 16, 2015 | 15:28PM EST
  11. Mid-Day Market Update: Youku Tudou Jumps Following Announcement of Proposal from Alibaba; Quanta Services Shares Slide

    Benzinga | Oct. 16, 2015 | 12:22PM EST
  12. Mid-Morning Market Update: Markets Edge Higher; General Electric Profit Tops Expectations

    Benzinga | Oct. 16, 2015 | 10:08AM EST
  13. Morning Market Losers

    Benzinga | Oct. 16, 2015 | 09:51AM EST
  14. CNBC's Stock Pops & Drops From February 26

    Benzinga | Feb. 27, 2015 | 06:55AM EST
  15. Fast Money Picks For February 23: Facebook, Cempra And More

    Benzinga | Feb. 23, 2015 | 06:32AM EST
  16. Benzinga's Top Initiations

    Benzinga | Feb. 10, 2015 | 09:15AM EST
  17. Janney Capital Initiates Cempra At Buy

    Benzinga | Feb. 10, 2015 | 09:07AM EST
  18. Does Cempra Have The Next Blockbuster Drug?

    GuruFocus | Jan. 8, 2015 | 12:06PM EST
  19. 4 More Biotech Secondaries Investors Are Watching

    Benzinga | Jan. 7, 2015 | 12:50PM EST
  20. Monday's After-Hours Market Movers

    Benzinga | Jan. 5, 2015 | 18:53PM EST
  21. Benzinga's Volume Movers

    Benzinga | Jan. 5, 2015 | 10:38AM EST
  22. Mid-Morning Market Update: Markets Open Lower; General Motors U.S. Sales Surge 19%

    Benzinga | Jan. 5, 2015 | 10:28AM EST
  23. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 5, 2015 | 10:24AM EST
  24. Morning Market Movers

    Benzinga | Jan. 5, 2015 | 09:47AM EST
  25. Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm Cell Therapeutics And More

    Benzinga | Jan. 5, 2015 | 09:31AM EST
  26. 5 Stocks To Watch On The First Day Of 2015

    Benzinga | Jan. 1, 2015 | 14:38PM EST
  27. 3 Companies To Watch On Social Media This New Year's Eve

    Benzinga | Dec. 31, 2014 | 11:02AM EST
  28. Benzinga's Volume Movers

    Benzinga | Dec. 31, 2014 | 10:35AM EST
  29. UPDATE: Stifel Reiterates Raises PT On Cempra On Good Risk/Reward Profile

    Benzinga | Dec. 31, 2014 | 07:31AM EST
  30. Cellceutix Corp Shares Rise On Two Catalysts

    Benzinga | Dec. 9, 2014 | 09:28AM EST
  31. Mid-Day Gainers From December 8: Cubist Pharmaceuticals, Acceleron Pharma, Calithera Biosciences, Cempra, Isis Pharmaceuticals

    Benzinga | Dec. 8, 2014 | 13:00PM EST
  32. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  33. US Stock Futures Flat; Fed Minutes In Focus

    Benzinga | Nov. 19, 2014 | 07:23AM EST
  34. Morning Market Losers

    Benzinga | Sep. 29, 2014 | 09:48AM EST
  35. Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial

    Benzinga | Sep. 25, 2014 | 16:05PM EST
  36. Cempra, Inc. Receives $10M Milestone Payment From Toyama Chemical Co. Triggered By Solithromycin's Clinical Development Progress In Japan

    Benzinga | Sep. 9, 2014 | 08:03AM EST
  37. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 18:25PM EST
  38. Benzinga's Top Initiations

    Benzinga | Apr. 8, 2014 | 08:53AM EST
  39. UPDATE: Leerink Swann Reiterates on Cempra Driven by Solithromycin Updates

    Benzinga | Nov. 18, 2013 | 11:14AM EST
  40. Cempra's CEM-101 Wins Qualified Infectious Disease Product Designation from FDA

    Benzinga | Sep. 6, 2013 | 08:03AM EST
  41. Cempra Inc. Doses First Patients in Solithromycin (CEM-101) Phase 2 Trial in Uncomplicated Urogenital Gonococcal Infections

    Benzinga | Jun. 12, 2012 | 02:05AM EST
Trading Center